Few U.S. adults in their 50s receive shingles vaccine

09/11/2013 | Healio · Bloomberg

Although the proportion of 50- to 59-year-olds receiving the herpes zoster vaccine jumped from 2.9% in 2008 to 4.3% in 2011, the rate remained relatively low, according to a study presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy. Among adults aged 60 and older, the vaccination rate substantially increased from 6.7% in 2008 to 15.8% in 2011. "Socioeconomic factors such as income, education, race, and type of insurance may influence likelihood to be vaccinated," study author Melissa D. Johnson said.

View Full Article in:

Healio · Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA